PD Neurotechnology is a medical device company with a focus on patient monitoring systems for movement disorders.
PD Neurotechnology has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
PD Neurotechnology's investors include National Bank of Greece, Big Pi Ventures, Crimson International Investment, ONASSIS FOUNDATION, NBG Business Seeds.
PD Neurotechnology is headquartered in London, United Kingdom.
PD Neurotechnology is a medical device company with a focus on patient monitoring systems for movement disorders.
PD Neurotechnology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PD Neurotechnology — Funding & Investors." VCBacked, April 25, 2023, https://www.vcbacked.co/company/pd-neurotechnology. Accessed August 14, 2026.
VCBacked. (2023). PD Neurotechnology — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pd-neurotechnology
{{cite web |title=PD Neurotechnology — Funding & Investors |url=https://www.vcbacked.co/company/pd-neurotechnology |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated